pALD Lenti Protocol and Sequence Request

Confidential Disclosure Agreement

These sequences and the protocol, specifically the ratios of the plasmids, are intellectual property owned by Oxgene for use by Aldevron and Aldevron’s clients. This information may be transferred to vendors for the sole purpose of performing work on your behalf and with whom you have a confidentiality agreement.  You must identify this information as confidential and subject to the confidentiality agreement and you must email with the name of the company to whom you disclosed this information.  Any other transfer of this information is prohibited. We may notify Oxgene that you have requested this information but no other information will be transferred.

By completing this form you agree to keep this information confidential and treat it with the same care and regard as confidential information of your organization.  If you do not agree to the terms outlined on this page, do not complete this form.  The confidentiality and disclosure obligations you accept by completing this form are in addition to any confidentiality agreement you have with Aldevron.  When completing this form, please use a business email address.

You will receive a link to a secure web page that requires you register and set up a username and password.  After you set up your account you will be able to download the files.  The files are password protected and, after you register, you will receive an email with the password to open the files.

Already registered?

Log in here

Request pALD Lenti documentation